Jung Yochun, Ahn Byoung Hee, Lee Kyo Seon, Jeong In Seok, Kim Kye Hun, Na Kook Joo, Ryu Sang-Wan, Oh Sang Gi
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, South Korea.
Department of Cardiovascular Medicine, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, South Korea.
Interact Cardiovasc Thorac Surg. 2017 Mar 1;24(3):342-347. doi: 10.1093/icvts/ivw361.
Prosthetic valve dehiscence after aortic valve surgery in Behçet's disease patients is common. We aimed to validate the usefulness of our new technique 'subannular endomyocardial implantation of valve prosthesis' designed to prevent prosthetic valve dehiscence.
Subannular endomyocardial implantation of valve prosthesis involves suturing the sewing cuff of the valve prosthesis in the endomyocardium below the aortic annulus, which is based on the idea that annular tissue should be excluded from the suture line in Behçet's disease patients. Medical records of 7 patients in whom the new technique was performed between 2002 and 2014 were reviewed.
Five men and two women were included (median age, 44 years). Aortic root replacement was performed in 6 cases, and aortic valve replacement in 1. No operative mortality occurred. Postoperatively, complete atrioventricular block developed in 3 cases, and permanent pacemakers were implanted in 2. No reoperation was performed for prosthetic valve dehiscence during the median 7.8-year follow-up. One late death occurred due to sudden cardiac arrest 8.4 years after surgery. One additional permanent pacemaker was implanted for complete atrioventricular block, which developed at 4.2 years postoperatively. The last echocardiography (median, 6.7 years after surgery) revealed no paravalvular leakages.
Subannular endomyocardial implantation of valve prosthesis seems useful for preventing prosthetic valve dehiscence after aortic valve surgery for Behçet's disease. It poses a risk of complete atrioventricular block, but considering the high reoperation rate and mortality due to prosthetic valve dehiscence after conventional aortic valve surgery, this risk seems reasonable.
白塞病患者主动脉瓣手术后人工瓣膜裂开很常见。我们旨在验证我们设计的用于预防人工瓣膜裂开的新技术“瓣膜假体瓣环下心肌内膜植入术”的有效性。
瓣膜假体瓣环下心肌内膜植入术是将瓣膜假体的缝合袖口缝合在主动脉瓣环下方的心肌内膜中,其基于这样的理念,即在白塞病患者中应将瓣环组织排除在缝合线之外。回顾了2002年至2014年间接受新技术治疗的7例患者的病历。
包括5名男性和2名女性(中位年龄44岁)。6例行主动脉根部置换术,1例行主动脉瓣置换术。无手术死亡发生。术后,3例发生完全性房室传导阻滞,2例植入永久性起搏器。在中位7.8年的随访期间,未因人工瓣膜裂开而进行再次手术。1例患者在术后8.4年因心脏骤停发生晚期死亡。术后4.2年因完全性房室传导阻滞又植入了1台永久性起搏器。最后一次超声心动图检查(术后中位6.7年)显示无瓣周漏。
瓣膜假体瓣环下心肌内膜植入术似乎有助于预防白塞病患者主动脉瓣手术后的人工瓣膜裂开。它有导致完全性房室传导阻滞的风险,但考虑到传统主动脉瓣手术后人工瓣膜裂开导致的高再次手术率和死亡率,这种风险似乎是合理的。